Searched for
COPYCAT DRUGS
CEOs are getting ruthless about worker performanceCorporate leaders are increasingly prioritizing results over employee comfort, with CEOs like Unilever's Fernando Fernandez demanding "volu...- Hims earnings today: Why Hims & Hers Health stock dropped despite raising revenue forecast - here's what investors need to knowHims stock after Hims & Hers earnings: Hims & Hers Health shares dropped significantly after reporting a surprise first-quarter loss and re...
- White House Correspondents' dinner shooting suspect aired grievances against Trump in writings to familyAn armed man, Cole Tomas Allen, allegedly targeted Trump administration officials at the White House Correspondents' Association dinner, le...
- Novo Nordisk CEO warns of layoffs as Wegovy challenge heats upNovo Nordisk warned of ongoing competition from copycat versions of its obesity drug Wegovy and signaled possible layoffs due to slowing sa...
- Wegovy maker Novo Nordisk to reduce costs after $95 billion stock lossWegovy-maker Novo Nordisk said on Wednesday it will sharpen its commercial focus and reduce costs, after a major profit warning and new CEO...
- Wegovy maker Novo Nordisk to reduce costs after $95 billion stock lossNovo Nordisk, the maker of Wegovy, will focus on commercial strategy and cost reduction. This decision follows a profit warning and a chang...
- US lawmakers press FDA to target knockoff weight-loss drugsUS lawmakers are pushing the Food and Drug Administration to control the increasing market of fake weight-loss medications. Concerns are ri...
- Natco, Onyx settle cancer drug patent litigationThe Indian generic drug maker had partnered with Breckenridge Pharmaceutical for marketing its Carfilzomib injection in the US market.
- Japan's drug regulator PMDA plans India officeJapan wants to lower healthcare costs by encouraging generic drugs. It's looking to double the share of generics in its healthcare system t...
- Japan's drug regulator PMDA set to open office in IndiaThe move is expected to help Indian generic drug manufacturers, which have been seeking to increase their presence in Japan.
- US Patents rejects Teva's plea on Copaxone; Natco shares upHyderabad-based Natco markets Copaxone (Glatiramer Acetate) -- used in the treatment of relapsing-remitting multiple sclerosis -- in the US...
- Why SC ruling won't bring down drug pricesDespite the SC verdict, Indian generics makers won't be falling over each other to take on Big Pharma and launch cheaper versions of their ...
- Ranbaxy set to get USFDA nod for Lipitor generic launch"The FDA has been very positive about Ranbaxy's intent to launch the product and we are working towards meeting the launch timeline", a per...
- DRL faces patent suit in US over allergy genericNYSE-listed Dr Reddy’s Laboratories (DRL) is embroiled in a fresh patent infringement row with US-based drug-discovery firm Albany Molecula...
- Lupin settles case with WyethLupin has struck an out-of-court settlement with Wyeth relating to the foreign company’s antidepressant ‘Effexor XR’ capsules.
- Cipla opposes patent for GSK’s cancer drugCipla has filed a grant opposition in the Kolkata patent office against GSK's newly-launched breast cancer drug on grounds of obviousness a...
- In a major pain relief, court upholds Troikaa’s drug patent Of generic drugPharma cos building blockbuster brands of generic drugs can rest easy. In a landmark judgement, Gujarat HC has upheld the design patent of ...
- US senators move bill to ban copycat generics productsThree US senators have introduced a bill in the US senate to try and prevent global pharma giants from selling cheaper copies of their own ...
- Dr Reddy's may land a major role in Plavix patent playWith the block-the-sale request filed by Bristol-Myers Squibb (BMS) and partner Sanofi-Aventis against Apotex’s brazen launch of generic ‘P...
- A twist in the patent taleGeneric drugmaker has stunned the pharma world by coming out with a generic version of Plavix,.
Load More
